Your browser doesn't support javascript.
loading
WHSC1 is involved in DNA damage, cellular senescence and immune response in hepatocellular carcinoma progression.
Yan, Jia; Zhang, Ming Yang; Lin, Jing; Li, Ke Xin; Zhao, Zhi Min; Gao, Yu Min; Deng, Xiu Ling; Wang, Chang Shan; Wang, Hai Sheng.
Afiliação
  • Yan J; School of Basic medical, Inner Mongolia Medical University, Hohhot, Inner Mongolia, China.
  • Zhang MY; School of Life science, Inner Mongolia University, Hohhot, Inner Mongolia, China.
  • Lin J; School of Life science, Inner Mongolia University, Hohhot, Inner Mongolia, China.
  • Li KX; Department of Nutrition, Affiliated Hospital of Inner Mongolia Medical University, Hohhot, Inner Mongolia, China.
  • Zhao ZM; School of Life science, Inner Mongolia University, Hohhot, Inner Mongolia, China.
  • Gao YM; School of Life science, Inner Mongolia University, Hohhot, Inner Mongolia, China.
  • Deng XL; School of Public health, Inner Mongolia Medical University, Hohhot, Inner Mongolia, China.
  • Wang CS; School of Basic medical, Inner Mongolia Medical University, Hohhot, Inner Mongolia, China.
  • Wang HS; School of Life science, Inner Mongolia University, Hohhot, Inner Mongolia, China.
J Cell Mol Med ; 27(10): 1436-1441, 2023 05.
Article em En | MEDLINE | ID: mdl-37073435
ABSTRACT
Wolf-Hirschhorn syndrome candidate 1 (WHSC1) is a transcriptional regulatory protein that encodes a histone methyltransferase to control H3K36me2 modification. WHSC1 was upregulated and associated with poor prognosis in HCC. The elevated WHSC1 likely due to the alterations of DNA methylation or RNA modification. WHSC1 perhaps form a chromatin cross talk with H3K27me3 and DNA methylation to regulate transcription factors expression in HCC. Functional analysis indicated that WHSC1 was involved in DNA damage repair, cell cycle, cellular senescence and immune regulations. Furthermore, WHSC1 was associated with the infiltrating levels of B cell, CD4+, Tregs and macrophage cells. Therefore, our findings suggested that WHSC1 might function as a promotor regulator to affect the development and progression of HCC. Thus, WHSC1 could be a potential biomarker in predicting the prognosis and therapeutic target for patients with HCC.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: J Cell Mol Med Assunto da revista: BIOLOGIA MOLECULAR Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: J Cell Mol Med Assunto da revista: BIOLOGIA MOLECULAR Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China
...